The Korea Pharmaceutical Bio Association establishes Pharmaceutical Bio Vision 2030 to mark the 80th anniversary of its foundation...Ryu Deok-hee, Honorary Chairman of Kyungdong Pharmaceutical Co., Ltd., Korea Pharmaceutical Co., Ltd
Feb 25, 2025
|
At the 80th regular general meeting held on the 25th, the association approved and finalized the 2025 budget (including 3.5855 billion won in projects to commemorate the 80th anniversary of its establishment) and business plan worth a total of 12.47 billion won. In addition, it also decided to revise the articles of incorporation to compensate for the deficiencies of the current articles of incorporation and the 2024 settlement plan. It also reported on the reappointment of Chairman Roh Yeon-hong and the re-appointment of adviser Won Hee-mok, who was voted on at the first board meeting in 2025 held on the 18th.
The general meeting was attended by many domestic and foreign guests, including Han Ji-ah, a member of the People's Power, Lee Ju-young, a member of the Reform New Party, Jung Eun-young, director of the Health and Industry Policy Bureau of the Ministry of Health and Welfare, and Kim Sang-bong, director of the Food and Drug Safety Bureau, Choi Kwang-hoon, chairman of the Korean Pharmaceutical Association, and Park Ho-young, chairman of the Korea Pharmaceutical Distribution Association, who jointly enacted and presented the Korean Pharmaceutical Business Awards.
|
Chairman Roh Yeon-hong will make a great leap forward for the next 100 years based on the 80 years of challenges and innovation that the association has accumulated since the beginning of the Joseon Pharmaceutical Industry Association in 1945"In response to the great transformation of the industrial paradigm, we will increase R&D capabilities for new drugs, demonstrate industrial competitiveness and future value by targeting customized overseas markets, and focus on establishing ethical management to establish itself as an industry trusted by the public."," he stressed.
In order to realize the vision of 'K-Pharma, a healthy future for Korea' this year, which marks its 80th anniversary, the association set the three major business goals of establishing a national health safety net by leap forward as a leading country in new drug development, increasing global performance, and strengthening manufacturing capabilities.
In order to materialize these goals, the association also confirmed three strategies and 12 detailed tasks (see attached), such as ▲ establishing an innovative growth ecosystem for new drug development ▲ enhancing global competitiveness of pharmaceutical bio ▲ enhancing drug access and strengthening social responsibility.
It will also actively promote projects to commemorate the 80th anniversary of its foundation. The association plans to hold future vision projects such as the establishment of ▲ Pharmaceutical Bio Vision 2030, public offering of emblems and logons, and the establishment of (tentative name) Future Hall, as well as ▲ Digital History Hall and Exhibition Hall, 80-year-old production, publication of domestic development new pharmaceutical white papers and drug advertising white papers, pharmaceutical bio open houses, advertising and campaign exhibitions, etc. ▲ Academic events such as global pharmaceutical development, AI Pharma Korea Conference, and manufacturing innovation forum ▲ 80th anniversary ceremony and opening ceremony of the Future Hall in sequence by the end of this year.
This article was translated by Naver AI translator.
